IBS – 4 symptoms that extend beyond your stomach

Unfortunately doctors still don’t know what causes irritable bowel syndrome (IBS) but they believe that a combination of problems can lead to the condition.

They do , however, know that functional gastrointestinal (GI) disorders, such as IBS, are problems with brain-gut interaction (i.e. how your brain and stomach work together), according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

 

Founded in February 2014, 4D Pharma (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D’s live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D has completed a phase I study in Irritable Bowel Syndrome and has completed dosing in a phase I study in Paediatric Crohn’s Disease. It currently has a pipeline of 13 pre-clinical programmes, covering disease areas such as cancer, poorly controlled asthma, autoimmune and CNS disease, and plans to commence four additional clinical studies in 2018.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    4d Pharma Plc

    More articles like this

    4d Pharma Plc

    People with fibromyalgia have different gut bacteria

    A study that compared women with and without fibromyalgia has, for the first time, linked gut bacteria to the long-lasting disease and its main symptoms. Researchers in Canada identified 19 species of gut bacteria that were

    4d Pharma Plc

    Findings link gut bacteria and Fibromyalgia

    Fibromyalgia affects 2-4 percent of the population and has no known cure. Symptoms include fatigue, impaired sleep, and cognitive difficulties, but the disease is most clearly characterized by widespread chronic pain. As reported in the journal Pain,

    4d Pharma Plc

    Gut bacteria: The surprising impact of viruses

    The microbiome plays a vital role in health. A recent study has investigated how viruses that kill gut bacteria influence these microbes. The findings make an already complicated picture much more so. The microbiome is both

    4d Pharma Plc

    4D pharma plc Presents MRx0518 combination study at ASCO

    4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined with KEYTRUDA® in patients with solid

    4d Pharma Plc

    4D pharma plc Directors purchase more shares in company

    4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood, Duncan Peyton and Alex Stevenson have purchased ordinary shares in the Company as listed below. Following this transaction,

    4d Pharma Plc

    4D pharma plc Presents Phase Ib Clinical Data on Thetanix

    4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, today announced that data from the completed Phase Ib clinical study of Thetanix® for the treatment of Crohn’s disease will be

    4d Pharma Plc

    Can this food additive turn our gut bacteria against us?

    E171 is a food additive that manufacturers use to whiten various products, including chewing gum, cake icing, and candy, for instance. While the addition of this substance may render certain products more appealing, there is an

    4d Pharma Plc

    7 Things Doctors Want You To Know About IBS

    Irritable bowel syndrome, or IBS, is one of those health conditions that can be difficult to talk about. And when you are struggling with things like diarrhea, constipation, gas, and bloating, it’s completely understandable. But there

    4d Pharma Plc

    4D pharma plc Participation in Microbiome Conference

    4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the inaugural Chardan Capital Markets LLC Microbiome Medicines Summit. Alex Stevenson, 4D’s Chief Scientific Officer, gave a